February 14, 2018 / 9:29 PM / 5 months ago

BRIEF-Vanda Pharmaceuticals Qtrly Net Loss Per Share $0.04

Feb 14 (Reuters) - Vanda Pharmaceuticals Inc:

* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER 2017 AND FULL YEAR 2017 FINANCIAL RESULTS

* ‍NON-GAAP NET INCOME FOR Q4 OF 2017, WAS $0.03 PER SHARE​

* QTRLY TOTAL REVENUES $44.3 MILLION VERSUS $38.2 MILLION

* ‍FULL YEAR 2018 FINANCIAL OBJECTIVES INCLUDES YEAR-END 2018 CASH $115 MILLION TO $125 MILLION​

* QTRLY NET LOSS PER SHARE $0.04

* Q4 EARNINGS PER SHARE VIEW $-0.12, REVENUE VIEW $43.5 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below